Orit Blumenfeld
Research Subjects
Research Interests
Orit Blumenfeld has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Lital Keinan-Boker
Israel Center for Disease Control, Ministry of Health, Ramat Gan, Israel
4 shared publicationsDavid Goitein
Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel
3 shared publications- Itamar Raz
Institution of Liver Diseases, Hadassah Medical Organization, Hadassah-Hebrew University, Jerusalem 91120, Israel
3 shared publications - Nasser Sakran
Holy Family Hospital, The Azireli Faculty of Medicine, Bar Ilan University, Nazareth, Israel
3 shared publications Tamy Shohat
Israel Center for Disease Control, Israel Ministry of Health, Jerusalem, Israel
3 shared publicationsAlina Rosenberg
Israel Center for Disease Control, Ministry of Health, Ramat-Gan, Israel
2 shared publications
Latest Publications
- Open Access
- 16 December 2023
- Published by Elsevier in Infection Prevention in Practice
- Vol. 6 (1) , 100334
The effect of COVID-19 vaccination on 30-day mortality after cardiac surgery – Insights from the Israel national registries
- 16 December 2023
- Published by Elsevier in Infection Prevention in Practice
- Vol. 6 (1) , 100334
Open AccessThe effect of COVID-19 vaccination on 30-day mortality after cardiac surgery – Insights from the Israel national registries
- 1 December 2023
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 18 (4) , 233-240
Quality of Life, Depression, and Food Tolerance, After Primary Sleeve Gastrectomy Among Israeli Patients: A Cross-Sectional National Study
Background: Adequate data on quality-of-life (QoL) after sleeve gastrectomy (SG) is scarce. Our aim was to study QoL, depression, and food tolerance after primary SG. Methods: Validated, well-accepted questionnaires targeting QoL (36-Item Short Form Survey Instrument [SF-36], Moorehead-Ardelt Quality of Life II (MA II), depression (Center for Epidemiologic Studies Depression Scale [CES-D]), and food tolerance (food tolerance score [FTS]) were administered to two distinct cohorts: “Operated”: A random sample of patients who underwent primary SG, “Candidate”: Candidates for primary bariatric surgery. Results: The “operated” cohort included 160 patients. Mean time from surgery and mean age were 4.4 ± 0.3 and 44.9 ± 12.1 years, respectively. Sixty two percent were female. The “candidate” cohort included 517 patients with a mean age of 38.1 ± 11.9 years, 75% of which were female. All participants completed the questionnaires (N = 677). Physical function QoL scores in the “operated” and “candidate” cohorts were 76.6 ± 14.9 and 58.2 ± 20.1 (p < 0.0001), respectively, for SF-36 and 0.08 ± 0.3 and −0.01 ± 0.3 (p < 0.0001), respectively, for MA II. Mental health scores in the “operated” and the “candidate” cohorts were 74.7 ± 15.2 and 64.1 ± 19.4 (p < 0.0001), respectively. The “operated” cohort scored better on the CES-D but worse on FTS (p < 0.0001 for both). Conclusion: Patients undergoing SG surgery report better QoL scores 4–5 years following the procedure than candidates. However, bariatric surgery candidates report better FTSs. Clinical Trial Registration Number: #NOH-161-2017.
- 1 December 2023
- Published by SAGE Publications in Bariatric Surgical Practice and Patient Care
- Vol. 18 (4) , 233-240
Quality of Life, Depression, and Food Tolerance, After Primary Sleeve Gastrectomy Among Israeli Patients: A Cross-Sectional National Study
Background: Adequate data on quality-of-life (QoL) after sleeve gastrectomy (SG) is scarce. Our aim was to study QoL, depression, and food tolerance after primary SG. Methods: Validated, well-accepted questionnaires targeting QoL (36-Item Short Form Survey Instrument [SF-36], Moorehead-Ardelt Quality of Life II (MA II), depression (Center for Epidemiologic Studies Depression Scale [CES-D]), and food tolerance (food tolerance score [FTS]) were administered to two distinct cohorts: “Operated”: A random sample of patients who underwent primary SG, “Candidate”: Candidates for primary bariatric surgery. Results: The “operated” cohort included 160 patients. Mean time from surgery and mean age were 4.4 ± 0.3 and 44.9 ± 12.1 years, respectively. Sixty two percent were female. The “candidate” cohort included 517 patients with a mean age of 38.1 ± 11.9 years, 75% of which were female. All participants completed the questionnaires (N = 677). Physical function QoL scores in the “operated” and “candidate” cohorts were 76.6 ± 14.9 and 58.2 ± 20.1 (p < 0.0001), respectively, for SF-36 and 0.08 ± 0.3 and −0.01 ± 0.3 (p < 0.0001), respectively, for MA II. Mental health scores in the “operated” and the “candidate” cohorts were 74.7 ± 15.2 and 64.1 ± 19.4 (p < 0.0001), respectively. The “operated” cohort scored better on the CES-D but worse on FTS (p < 0.0001 for both). Conclusion: Patients undergoing SG surgery report better QoL scores 4–5 years following the procedure than candidates. However, bariatric surgery candidates report better FTSs. Clinical Trial Registration Number: #NOH-161-2017.
- 12 April 2022
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 30 (3)
Do Mechanically Ventilated COVID-19 Patients Present a Higher Case-Fatality Rate Compared With Other Infectious Respiratory Pandemics? A Systematic Review and Meta-Analysis
Background Early reports on COVID-19 patient outcomes showed a marked fatality rate among patients requiring invasive mechanical ventilation (IMV). Objective Our aim was to compare case fatality rate (CFR) outcomes for patients requiring IMV due to severe acute respiratory syndrome (SARS)-associated coronavirus 2 (COVID-19), SARS-associated coronavirus 1, Middle East respiratory syndrome (MERS), and influenza (H1N1). Materials and Methods We searched PubMed, EMBASE, MEDLINE, Google Scholar, and Cochrane Library for relevant studies published between December 2019 and April 2021 for COVID-19, between January 2002 and December 2008 for SARS, between January 2012 and December 2019 for MERS, and between January 2009 and December 2016 for influenza (H1N1). Results Overall, this study included 81 peer-reviewed studies, pertaining to 65,058 patients requiring IMV: 61 studies including 62,809 COVID-19 patients, 4 studies including 148 SARS patients, 9 studies including 875 MERS patients, and 7 studies including 1226 influenza (H1N1) patients. The CFR for COVID-19 patients requiring IMV was not significantly different from the CFR for SARS and influenza (H1N1) patients (45.5% [95% confidence interval (CI), 38.5%–52.8%] vs. 48.1% [95% CI, 39.2%–57.2%] and 39.7% [95% CI, 29.3%–51.3%], respectively). However, CFR for COVID-19 patients was significantly lower compared with that for MERS patients (CFR, 70.6%; 95% CI, 60.9%–78.8%). Conclusions COVID-19 patients requiring IMV show a similar CFR compared with SARS and H1N1 influenza patients but a lower CFR compared with MERS patients. To improve survival in future pandemics, we recommend examining the pros and cons of the liberal use of endotracheal intubation and considering drafting guidelines for the selection of patients to intubate and the timing of intubation.
- 12 April 2022
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 30 (3)
Do Mechanically Ventilated COVID-19 Patients Present a Higher Case-Fatality Rate Compared With Other Infectious Respiratory Pandemics? A Systematic Review and Meta-Analysis
Background Early reports on COVID-19 patient outcomes showed a marked fatality rate among patients requiring invasive mechanical ventilation (IMV). Objective Our aim was to compare case fatality rate (CFR) outcomes for patients requiring IMV due to severe acute respiratory syndrome (SARS)-associated coronavirus 2 (COVID-19), SARS-associated coronavirus 1, Middle East respiratory syndrome (MERS), and influenza (H1N1). Materials and Methods We searched PubMed, EMBASE, MEDLINE, Google Scholar, and Cochrane Library for relevant studies published between December 2019 and April 2021 for COVID-19, between January 2002 and December 2008 for SARS, between January 2012 and December 2019 for MERS, and between January 2009 and December 2016 for influenza (H1N1). Results Overall, this study included 81 peer-reviewed studies, pertaining to 65,058 patients requiring IMV: 61 studies including 62,809 COVID-19 patients, 4 studies including 148 SARS patients, 9 studies including 875 MERS patients, and 7 studies including 1226 influenza (H1N1) patients. The CFR for COVID-19 patients requiring IMV was not significantly different from the CFR for SARS and influenza (H1N1) patients (45.5% [95% confidence interval (CI), 38.5%–52.8%] vs. 48.1% [95% CI, 39.2%–57.2%] and 39.7% [95% CI, 29.3%–51.3%], respectively). However, CFR for COVID-19 patients was significantly lower compared with that for MERS patients (CFR, 70.6%; 95% CI, 60.9%–78.8%). Conclusions COVID-19 patients requiring IMV show a similar CFR compared with SARS and H1N1 influenza patients but a lower CFR compared with MERS patients. To improve survival in future pandemics, we recommend examining the pros and cons of the liberal use of endotracheal intubation and considering drafting guidelines for the selection of patients to intubate and the timing of intubation.
- Open Access
- 5 April 2022
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 17 (1) , 1-7
Validation of the society of thoracic surgeons predicted risk of mortality score for long-term survival after cardiac surgery in Israel
Background: Long-term survival is an important metric in assessing procedural value. We previously confirmed that the Society of Thoracic Surgeons predicted risk of mortality score (PROM) accurately predicts 30-day mortality in Israeli patients. The present study investigated the ability of the PROM to reliably predict long-term survival.Methods: Data on 1279 patients undergoing cardiac surgery were prospectively entered into our database and used to calculate PROM. Long-term mortality was obtained from the Israeli Social Security Database. Patients were stratified into five cohorts according to PROM (A: 0–0.99%, B: 1.0–1.99%, C: 2.0–2.99%, D: 3.0–4.99% and E: ≥ 5.0%). Kaplan–Meier estimates of survival were calculated for each cohort and compared by Wilcoxon signed-rank test. We used C-statistics to assess model discrimination. Cox regression analysis was performed to identify predictors of long-term survival.Results: Follow-up was achieved for 1256 (98%) patients over a mean period of 62 ± 28 months (median 64, range 0–107). Mean survival of the entire cohort was 95 ± 1 (95% CI 93–96) months. Higher PROM was associated with reduced survival: A—104 ± 1 (103–105) months, B—96 ± 2 (93–99) months, C—93 ± 3 (88–98) months, D—89 ± 3 (84–94) months, E—74 ± 3 (68–80) months (p < 0.0001). The Area Under the Curve was 0.76 ± 0.02 indicating excellent model discrimination. Independent predictors of long-term mortality included advanced age, lower ejection fraction, reoperation, diabetes mellitus, dialysis and PROM.Conclusions: The PROM was a reliable predictor of long-term survival in Israeli patients undergoing cardiac surgery. The PROM might be a useful metric for assessing procedural value and surgical decision-making.
- 5 April 2022
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 17 (1) , 1-7
Open AccessValidation of the society of thoracic surgeons predicted risk of mortality score for long-term survival after cardiac surgery in Israel
Background: Long-term survival is an important metric in assessing procedural value. We previously confirmed that the Society of Thoracic Surgeons predicted risk of mortality score (PROM) accurately predicts 30-day mortality in Israeli patients. The present study investigated the ability of the PROM to reliably predict long-term survival.Methods: Data on 1279 patients undergoing cardiac surgery were prospectively entered into our database and used to calculate PROM. Long-term mortality was obtained from the Israeli Social Security Database. Patients were stratified into five cohorts according to PROM (A: 0–0.99%, B: 1.0–1.99%, C: 2.0–2.99%, D: 3.0–4.99% and E: ≥ 5.0%). Kaplan–Meier estimates of survival were calculated for each cohort and compared by Wilcoxon signed-rank test. We used C-statistics to assess model discrimination. Cox regression analysis was performed to identify predictors of long-term survival.Results: Follow-up was achieved for 1256 (98%) patients over a mean period of 62 ± 28 months (median 64, range 0–107). Mean survival of the entire cohort was 95 ± 1 (95% CI 93–96) months. Higher PROM was associated with reduced survival: A—104 ± 1 (103–105) months, B—96 ± 2 (93–99) months, C—93 ± 3 (88–98) months, D—89 ± 3 (84–94) months, E—74 ± 3 (68–80) months (p < 0.0001). The Area Under the Curve was 0.76 ± 0.02 indicating excellent model discrimination. Independent predictors of long-term mortality included advanced age, lower ejection fraction, reoperation, diabetes mellitus, dialysis and PROM.Conclusions: The PROM was a reliable predictor of long-term survival in Israeli patients undergoing cardiac surgery. The PROM might be a useful metric for assessing procedural value and surgical decision-making.
- 2 February 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (4) , 760-768
Outcomes of cardiac surgery in patients with end‐stage renal disease: Insights from the Israel national registries
Background End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. Methods The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. Results One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2–18.2), MVR procedure (HR = 1.5, 95% CI; 1.04–2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2–2.04). Conclusions Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
- 2 February 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (4) , 760-768
Outcomes of cardiac surgery in patients with end‐stage renal disease: Insights from the Israel national registries
Background End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. Methods The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. Results One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2–18.2), MVR procedure (HR = 1.5, 95% CI; 1.04–2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2–2.04). Conclusions Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
- 1 January 2020
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 16 (1) , 80-89
The Israel National Bariatric Surgery Registry: the inception process
- 1 January 2020
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 16 (1) , 80-89
The Israel National Bariatric Surgery Registry: the inception process
- 2 September 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (1) , 296-303
Comparative Effectiveness of Laparoscopic Adjustable Gastric Banding vs Laparoscopic Sleeve Gastrectomy in Adolescents—a National Registry-Based Study
Most published work on bariatric surgery (BS) in adolescents describes outcomes after laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass. We compared the efficacy of LAGB and laparoscopic sleeve gastrectomy (LSG) in adolescents.
- 2 September 2019
- Published by Springer Nature in Obesity Surgery
- Vol. 30 (1) , 296-303
Comparative Effectiveness of Laparoscopic Adjustable Gastric Banding vs Laparoscopic Sleeve Gastrectomy in Adolescents—a National Registry-Based Study
Most published work on bariatric surgery (BS) in adolescents describes outcomes after laparoscopic adjustable gastric banding (LAGB) or Roux-en-Y gastric bypass. We compared the efficacy of LAGB and laparoscopic sleeve gastrectomy (LSG) in adolescents.
- 10 July 2019
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (2) , 411-416
Prevalence of cerebral palsy with Gross Motor Function Classification System levels IV and V in children in Israel: a cross-cultural comparison
Cerebral palsy is the most common physical disability in childhood. Our aim was to study the prevalence of wheelchair-dependent cerebral palsy (equivalent to gross motor function classification system level IV/V) among Jewish and Arab children in Israel and to investigate differences between the children of the two population groups.
- 10 July 2019
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (2) , 411-416
Prevalence of cerebral palsy with Gross Motor Function Classification System levels IV and V in children in Israel: a cross-cultural comparison
Cerebral palsy is the most common physical disability in childhood. Our aim was to study the prevalence of wheelchair-dependent cerebral palsy (equivalent to gross motor function classification system level IV/V) among Jewish and Arab children in Israel and to investigate differences between the children of the two population groups.
- 25 April 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (9) , 2670-2671
Correction to: Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study
In Table 5 the P value for the parameter “More than one chronic disease” is incorrect. The correct value is 0.387, not 0.0387.
- 25 April 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (9) , 2670-2671
Correction to: Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study
In Table 5 the P value for the parameter “More than one chronic disease” is incorrect. The correct value is 0.387, not 0.0387.
- 7 April 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (9) , 2661-2669
Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study
Although bariatric surgery (BS) is considered safe, concern remains regarding severe post-operative adverse events and mortality. Using a national BS registry, the aim of this study was to assess the incidence, etiologies, and risk factors for mortality following BS.
- 7 April 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (9) , 2661-2669
Incidence and Risk Factors for Mortality Following Bariatric Surgery: a Nationwide Registry Study
Although bariatric surgery (BS) is considered safe, concern remains regarding severe post-operative adverse events and mortality. Using a national BS registry, the aim of this study was to assess the incidence, etiologies, and risk factors for mortality following BS.